- Home
- ATYR vs GDEV Comparison
ATYR vs GDEV Comparison
Compare ATYR & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- GDEV
- Stock Information
- Founded
- ATYR 2005
- GDEV 2009
- Country
- ATYR United States
- GDEV Cyprus
- Employees
- ATYR N/A
- GDEV N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- GDEV EDP Services
- Sector
- ATYR Health Care
- GDEV Technology
- Exchange
- ATYR Nasdaq
- GDEV Nasdaq
- Market Cap
- ATYR 105.8M
- GDEV 266.7M
- IPO Year
- ATYR 2015
- GDEV N/A
- Fundamental
- Price
- ATYR $1.04
- GDEV N/A
- Analyst Decision
- ATYR Buy
- GDEV
- Analyst Count
- ATYR 6
- GDEV 0
- Target Price
- ATYR $8.88
- GDEV N/A
- AVG Volume (30 Days)
- ATYR 14.9M
- GDEV 25.1K
- Earning Date
- ATYR 11-06-2025
- GDEV 11-13-2025
- Dividend Yield
- ATYR N/A
- GDEV N/A
- EPS Growth
- ATYR N/A
- GDEV 12.96
- EPS
- ATYR N/A
- GDEV 2.56
- Revenue
- ATYR N/A
- GDEV $425,112,000.00
- Revenue This Year
- ATYR $420.85
- GDEV N/A
- Revenue Next Year
- ATYR $1,513.40
- GDEV $1.39
- P/E Ratio
- ATYR N/A
- GDEV $9.67
- Revenue Growth
- ATYR N/A
- GDEV N/A
- 52 Week Low
- ATYR $0.68
- GDEV $8.60
- 52 Week High
- ATYR $7.29
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- ATYR 31.98
- GDEV 45.89
- Support Level
- ATYR $0.68
- GDEV $31.21
- Resistance Level
- ATYR $1.12
- GDEV $42.20
- Average True Range (ATR)
- ATYR 0.09
- GDEV 5.16
- MACD
- ATYR 0.18
- GDEV -0.89
- Stochastic Oscillator
- ATYR 81.75
- GDEV 15.26
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.